z-logo
open-access-imgOpen Access
Targeted therapies for unresectable stage III non-small cell lung cancer
Author(s) -
Jordi Remón,
Lizza E.L. Hendriks
Publication year - 2021
Publication title -
mediastinum
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2522-6711
DOI - 10.21037/med-21-8
Subject(s) - anaplastic lymphoma kinase , medicine , oncology , lung cancer , population , epidermal growth factor receptor , adverse effect , chemoradiotherapy , tyrosine kinase , cancer , receptor , environmental health , malignant pleural effusion

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom